Tirzepatide
Batch HXTZ260212
Batch specifications, testing provenance and original laboratory evidence maintained in our supply documentation.
Structured results
Batch test metrics
| Test / analyte | Result | Unit | Method | Specification | Assessment |
|---|---|---|---|---|---|
| Petide Content | 95.1 | % | — | NLT 85.0% | Pass |
| Assay | 98.4 | % | — | 95.0%~105.0%(anhydrous and sodium free) | Pass |
| Chromatographie Purity | 99.2 | % | — | NLT 99% | Pass |
| Sodium Content | 1.2 | % | — | NMT 5.0% | Pass |
| Methanol | < LOD | ppm | — | NMT 3000 ppm；LOD = 180 ppm | Pass |
| Acetonitrile | < LOD | ppm | — | NMT 410 ppm；LOD = 25 ppm | Pass |
| N,N-Dimethylformamide / DMF | < LOD | ppm | — | NMT 880 ppm；LOD = 53 ppm | Pass |
| Bacterial Endotoxins | Meet the requirements | EU/mg | — | < 5 EU/mg | Pass |
| Total Aerobic Bacteria Count | Meet the requirements | CFU/g | — | NMT 100 CFU/g | Pass |
| Total Yeasts and Molds Count | Meet the requirements | CFU/g | — | NMT 100 CFU/g | Pass |
Batch summary
Product and test information
- Product
- Tirzepatide
- Batch/Lot
- HXTZ260212
- Nominal vial size
- 40mg
- Packaging
- vial
- Manufacturing source
- Qualified manufacturing partner
- Test laboratory
- Nanjing Hanxin Pharmaceutical Technology Co., Ltd
- Sample submitted by
- Supplier
- Identity
- pass
- Quantity
- 1
- Test date
- 5/27/2026
- Current supply status
- Available
Original evidence
Original Batch Documents
7.16__替尔泊肽Tirzepatide__HXTZ260212.pdfOpen original
Batch-level provenance
This sample was submitted to the laboratory by our upstream manufacturing supplier. CGBPeptide did not independently control the sampling of this report.